Banner Image

Test Directory

Alkaline Phosphatase

Test Summary

Serum alkaline phosphatase levels are of interest in the diagnosis of hepatobiliary disorders and bone disease associated with increased osteoblastic activity. Moderate elevations of alkaline phosphatase may be seen in several conditions that do not involve the liver or bone. Among these are Hodgkin's disease, congestive heart failure, ulcerative colitis, regional enteritis, and intra-abdominal bacterial infections. Elevations are also observed during the third trimester of pregnancy.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum collected in a serum separator tube (SST)

Minimum Volume

0.5 mL

Instructions

Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: 28 days

Limitations

N/A

Other Acceptable Specimens

Plasma collected in: Sodium heparin (green-top) tube or lithium heparin (green-top) tube

Unacceptable Specimens

Anticoagulants other than heparin

Order Code

ALKPHS

EPIC (Premier) Code

N/A

Includes

N/A

CPT Code

  • 84075

Billing Code

  • 700000

CPT Statement

Methodology

Spectrophotometry (SP)

FDA Status

FDA Approved

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Reference Range

 Male (U/L) Female (U/L)
0-6 Days 46-245 46-245
7-14 Days 69-306 69-306
15 Days-<1 Month 113-412 113-412
1-5 Months 104-450 104-450
6-11 Months 100-334 100-334
1-9 Years 117-311 117-311
10 Years 128-396 128-396
11 Years 125-428 100-429
12 Years 123-426 69-296
13 Years 100-417 58-258
14 Years 78-326 51-179
15 Years 65-278 45-150
16 Years 56-234 41-140
17-19 Years 46-169 36-128
20-49 Years 36-130 31-125
>49 Years 35-144 37-153

Setup Schedule / Expected Turnaround Time

Daily, Report available: 1 day

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum collected in a serum separator tube (SST)

Minimum Volume

0.5 mL

Instructions

Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: 28 days

Limitations

N/A

Other Acceptable Specimens

Plasma collected in: Sodium heparin (green-top) tube or lithium heparin (green-top) tube

Unacceptable Specimens

Anticoagulants other than heparin

Billing

CPT Code

  • 84075

Billing Code

  • 700000

CPT Statement

Result Information

Methodology

Spectrophotometry (SP)

Testing Laboratory

N/A

Reference Range

 Male (U/L) Female (U/L)
0-6 Days 46-245 46-245
7-14 Days 69-306 69-306
15 Days-<1 Month 113-412 113-412
1-5 Months 104-450 104-450
6-11 Months 100-334 100-334
1-9 Years 117-311 117-311
10 Years 128-396 128-396
11 Years 125-428 100-429
12 Years 123-426 69-296
13 Years 100-417 58-258
14 Years 78-326 51-179
15 Years 65-278 45-150
16 Years 56-234 41-140
17-19 Years 46-169 36-128
20-49 Years 36-130 31-125
>49 Years 35-144 37-153

Setup Schedule / Expected Turnaround Time

Daily, Report available: 1 day